Literature DB >> 3021996

Bovine papillomavirus type 1 3' early region transformation and plasmid maintenance functions.

M S Rabson, C Yee, Y C Yang, P M Howley.   

Abstract

We examined bovine papillomavirus type 1 (BPV-1) DNAs mutated in the E2 open reading frame (ORF) to determine their ability (i) to transform C127 cells and (ii) to remain extrachromosomal in transfected cells. Results obtained with deletion mutants and insertion mutants containing a linker with translational termination codons in all possible reading frames indicated that an E2 ORF gene product(s) is necessary for efficient transformation, as well as viral plasmid replication and maintenance in the context of the full BPV-1 genome. Complementation assays in which mutant BPV-1 DNAs were transfected into cell lines expressing some viral functions from integrated BPV-1 cDNAs demonstrated that the E2 ORF product, when provided in trans, could allow BPV-1 E2 mutants to remain extrachromosomal. The E2 function could also augment transformation of some, but not all, BPV-1 E2 mutants, allowing identification of another region of BPV-1 involved in cellular transformation. It is likely that the role of the BPV-1 E2 product(s) in transformation and plasmid maintenance is indirect. A BPV-1 mutant altered in the E5 ORF is transformation defective and unable to replicate as a stable plasmid in C127 cells.

Entities:  

Mesh:

Year:  1986        PMID: 3021996      PMCID: PMC288935     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  A new dominant hybrid selective marker for higher eukaryotic cells.

Authors:  F Colbère-Garapin; F Horodniceanu; P Kourilsky; A C Garapin
Journal:  J Mol Biol       Date:  1981-07-25       Impact factor: 5.469

2.  Transformation and replication in mouse cells of a bovine papillomavirus--pML2 plasmid vector that can be rescued in bacteria.

Authors:  N Sarver; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

Review 3.  Animal papillomaviruses.

Authors:  W D Lancaster; C Olson
Journal:  Microbiol Rev       Date:  1982-06

4.  Virus-specific transcription in bovine papillomavirus-transformed mouse cells.

Authors:  C A Heilman; L Engel; D R Lowy; P M Howley
Journal:  Virology       Date:  1982-05       Impact factor: 3.616

5.  A quantitative in vitro focus assay for bovine papilloma virus.

Authors:  I Dvoretzky; R Shober; S K Chattopadhyay; D R Lowy
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

6.  The bovine papillomavirus distal "enhancer" is not cis essential for transformation or for plasmid maintenance.

Authors:  P M Howley; E T Schenborn; E Lund; J C Byrne; J E Dahlberg
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

7.  Bovine papilloma virus transcription: polyadenylated RNA species and assessment of the direction of transcription.

Authors:  E Amtmann; G Sauer
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

8.  Transcriptional control signals in the genome of bovine papillomavirus type 1.

Authors:  M S Campo; D A Spandidos; J Lang; N M Wilkie
Journal:  Nature       Date:  1983 May 5-11       Impact factor: 49.962

9.  Bovine papilloma virus contains an activator of gene expression at the distal end of the early transcription unit.

Authors:  M Lusky; L Berg; H Weiher; M Botchan
Journal:  Mol Cell Biol       Date:  1983-06       Impact factor: 4.272

10.  Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences.

Authors:  M F Law; D R Lowy; I Dvoretzky; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  57 in total

1.  Mutational analysis of the 3' open reading frames and the splice junction at nucleotide 3225 of bovine papillomavirus type 1.

Authors:  P L Hermonat; P M Howley
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated.

Authors:  H D Royer; M P Freyaldenhoven; I Napierski; D D Spitkovsky; T Bauknecht; N Dathan
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

Review 3.  Papillomavirus DNA replication.

Authors:  P F Lambert
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1.

Authors:  M Lusky; E Fontane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

5.  The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro.

Authors:  I L Blitz; L A Laimins
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Bovine papillomavirus E2 repressor mutant displays a high-copy-number phenotype and enhanced transforming activity.

Authors:  D J Riese; J Settleman; K Neary; D DiMaio
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

8.  Transcriptional and replicational activation functions in the bovine papillomavirus type 1 E2 protein are encoded by different structural determinants.

Authors:  A Abroi; R Kurg; M Ustav
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

Review 9.  The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango.

Authors:  Kristina Talbert-Slagle; Daniel DiMaio
Journal:  Virology       Date:  2008-11-06       Impact factor: 3.616

10.  Characterization of the cis elements involved in basal and E2-transactivated expression of the bovine papillomavirus P2443 promoter.

Authors:  B A Spalholz; S B Vande Pol; P M Howley
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.